GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Orient Gene Biotech Co Ltd (SHSE:688298) » Definitions » Research & Development

Zhejiang Orient Gene Biotech Co (SHSE:688298) Research & Development : ¥277.3 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Orient Gene Biotech Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Orient Gene Biotech Co's Research & Development for the three months ended in Mar. 2025 was ¥58.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥277.3 Mil.


Zhejiang Orient Gene Biotech Co Research & Development Historical Data

The historical data trend for Zhejiang Orient Gene Biotech Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Orient Gene Biotech Co Research & Development Chart

Zhejiang Orient Gene Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only 93.75 428.52 511.56 260.86 290.49

Zhejiang Orient Gene Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.97 74.34 63.58 80.61 58.73

Zhejiang Orient Gene Biotech Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥277.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Orient Gene Biotech Co  (SHSE:688298) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhejiang Orient Gene Biotech Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Orient Gene Biotech Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Orient Gene Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
3787 East Section of Yangguang Avenue, Dipu Street, Anji County, Zhejiang Province, Huzhou, CHN, 313300
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.

Zhejiang Orient Gene Biotech Co Headlines

No Headlines